(TeleManagement) According to a new review, statins are useless for patients with advanced stages of chronic kidney disease (CKD). This category of patients is more predisposed to the risks of developing cardiovascular disease. This review was published in the American Journal of Cardiovascular Drugs.
It is considered that in the advanced stages of this disease, statins will not decrease risks to cardiovascular disease. There was no significant difference in the number of cardiovascular events experienced by patients who received statins and those who received placebo. There was no significant difference in the occurrence of heart attack, stroke, or death from cardiovascular disease between patients who received statins and those who received placebo.
In addition, statins did not appear to slow the progression of kidney disease in any large clinical outcome study, as has been previously suggested.
“I believe the evidence shows that the majority of people with chronic kidney disease are taking statins inappropriately”, said lead review author Ali Olyaei, PharmD, a professor of pharmacotherapy in the College of Pharmacy at Oregon State University, in a press release. “They may help a little in early-stage disease, but those people are not the ones who generally die from cardiovascular diseases. And by the end stages the risks outweigh any benefit. More drugs are not always better”.
Graham
No comments:
Post a Comment